Dantonello, Tobias M <br/><br/>
Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma.  [electronic resource] 

 -  Pediatric blood & cancer  Jan 2015 
 - 16-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.25207  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Child<br/>Child, Preschool<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Lymphatic Metastasis<br/>Male<br/>Neoadjuvant Therapy<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Prognosis<br/>Retrospective Studies<br/>Rhabdomyosarcoma, Embryonal--drug therapy<br/>Survival Rate<br/>Tumor Burden<br/>Young Adult